IDL Diagnostics AB (publ)'s latest marketcap:
As of 08/02/2025, IDL Diagnostics AB (publ)'s market capitalization has reached $14.05 M. According to our data, IDL Diagnostics AB (publ) is the 38794th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 14.05 M |
| Revenue (ttm) | 6.22 M |
| Net Income (ttm) | -4,594,095.37 |
| Shares Out | 230.36 M |
| EPS (ttm) | -0.02 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/21/2025 |
IDL Diagnostics AB (publ)'s yearly market capitalization.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/02/2025 | kr135.91 M | $14.05 M | 47.69% | 38794 |
| 12/30/2024 | kr89.84 M | $8.08 M | -10.76% | 38994 |
| 12/29/2023 | kr100.67 M | $9.93 M | -29.52% | 37139 |
| 12/30/2022 | kr142.82 M | $13.63 M | 31.17% | 34610 |
| 12/30/2021 | kr108.88 M | $11.98 M | -38.54% | 34887 |
| 12/30/2020 | kr177.17 M | $21.44 M | 95.82% | 29172 |
| 12/30/2019 | kr90.48 M | $9.62 M | -0.66% | 29005 |
| 12/28/2018 | kr91.08 M | $10.24 M | -17.93% | 27790 |
| 12/29/2017 | kr110.97 M | $13.49 M | -45.49% | 26799 |
| 12/30/2016 | kr203.59 M | $22.27 M | -20.39% | 22873 |
Company Profile
AroCell AB (publ), a vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
It offers UBC Rapid, a point-of-care test for diagnosis and monitoring of bladder cancer; AroCell TK 210 ELISA, a biomarker for tumor cell; and TUBEX TF, a vitro diagnostic test for detection of acute typhoid fever.
The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006.
AroCell AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
Frequently Asked Questions
-
What is IDL Diagnostics AB (publ)'s (STO-IDLDX) current market cap?As of 08/02/2025, IDL Diagnostics AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $14.05 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does IDL Diagnostics AB (publ) (STO-IDLDX) rank globally by market cap?IDL Diagnostics AB (publ) global market capitalization ranking is approximately 38794 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.